Health group (n = 4569) | Risk group (n = 7434) | CKD group (n = 1573) | ||||
---|---|---|---|---|---|---|
Male (n = 1311) | Female (n = 3258) | Male (n = 3338) | Female (n = 4096) | Male (n = 676) | Female (n = 897) | |
Unadjusted rates of decline in eGFR | 0.51 ± 0.04* | 0.75 ± 0.03 | 0.53 ± 0.02* | 0.67 ± 0.02 | 0.89 ± 0.06 | 0.88 ± 0.06 |
Covariate-adjusted rates of decline in eGFR † | 0.52 ± 0.04* | 0.75 ± 0.04 | 0.62 ± 0.03* | 0.71 ± 0.03 | 0.94 ± 0.06 | 0.90 ± 0.08 |
Covariate-adjusted rates of decline in eGFR † (referenced to healthy group) | - | - | 0.10 ± 0.05& | -0.03 ± 0.04 | 0.44 ± 0.06& | 0.15 ± 0.06& |
Gender difference in covariate-adjusted rates of decline in eGFR † (referenced to healthy group) | - | 0.10 ± 0.06 | 0.29 ± 0.09# |